China Molecular Diagnostics Market & Volume Forecast, by Application

1
China Molecular Diagnostics Market
China Molecular Diagnostics Market
2
Report Description and Highlights
Molecular diagnostics plays an important role in
the identification of diseases and has gained
more public healthcare specialist attention
than ever before. The molecular diagnostics is a
technique used for the molecular biological
detection of any change in the structure or
expression of a patient's genetic material.
According to Renub Research, China Molecular
Diagnostics Market is expected to be US 6.3
Billion by 2026. In recent years, Molecular
diagnostics has changed the face of clinical
laboratories by offering easy to use automated
molecular systems that provide rapid results with
less hands-on time. However, huddles for China
diagnostic companies are Lack of Government
Support, Public Awareness for Molecular
Diagnostics test.
China Molecular Diagnostics Market
3
China Molecular Diagnostics Market
COVID-19 effect on Molecular Diagnostics
Industry Besides, COVID-19 has worked as a
catalyst for molecular diagnostics industry in
China. In order to spread the disease government
of China is doing massive number of COVID test.
The types of tests which are done to indentify
the coronavirus disease are RT-PCR, and rapid
anti-body tests also known as serological
tests. RT-PCR is considered the gold standard
frontline test. In this test testing is done by
taking a nasal/throat swab from a patient. This
test involves extracting ribonucleic acid or RNA,
which is the genetic material of the virus. This
is a fairly expensive test it requires RNA extract
ing machines, a laboratory and trained
technicians. On the other hand rapid anti-body
tests are portable, administered on-site, provide
quick answers and are inexpensive too.
China Molecular Diagnostics Market
4
China Molecular Diagnostics Market
China molecular diagnostics market is segmented
into three main categories Oncology Test,
Infectious Disease Test and Genetic Disease Test.
Further, Oncology Test has been segmented into
three types Prostate Cancer, Colorectal Cancer
and Breast Cancer. Infectious Disease Test has
been further categorized into two main types,
which is virology and HPV. Genetic Test has been
categorized into HLA and Blood Screening. Blood
screening test is a dominating segment in the
China molecular genetic testing market. According
to Renub Research analysis nearly 441
million molecular diagnostic tests will be
performed in China by the end of 2026 of which
Virology accounts for one of the most performed
tests segments. DICON Clinical Laboratories,
Zhejiang Dian Diagnostics Technology Co., Ltd,
Kindstar Global, BGI-Shenzhen, A, Guangzhou
Kingmed Diagnostics Center Co. Ltd and OriGene
Technologies holds majority of market share in
China. However, restriction on export is expected
to have minimal impact on the manufacturers as
the demand is very high in China which is
creating a robust revenue pool for manufacturers
dealing in the molecular diagnostics sector.
China Molecular Diagnostics Market
5
China Molecular Diagnostics Market
Renub Research report titled China Molecular
Diagnostics Market, Volume, by Application
Oncology Testing (Breast Cancer, Colorectal
Cancer, Prostate Cancer), Infectious Disease
Testing (Virology, HPV), and Genetic Disease
Testing (Blood Screening, HLA) provides a
complete analysis of China Molecular Diagnostics
Market. By Application The report studies the
market and volume of the following segments in
Molecular Diagnostics Infectious Disease Testing
(Virology, HPV), Oncology Testing (Breast Cancer,
Colorectal Cancer, Prostate Cancer), and Genetic
Disease Testing (Blood Screening, HLA).
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lchina-molecular-diagnostics-market-test-volume-a
nd-forecast-491-p.php
China Molecular Diagnostics Market
6
China Molecular Diagnostics Market
Forecast for China Molecular Diagnostics Market
Share () - Oncology Test (2020 - 2026)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
China Molecular Diagnostics Market
7
China Molecular Diagnostics Market
Segment Covered in this report are as
follows Oncology Testing Market and Volume   
 Breast Cancer    Colorectal Cancer  
 Prostate Cancer Infectious Disease Testing
Market and Volume     Virology   
 HPV Genetic Testing Market and Volume   
 Blood Screening    HLA
China Molecular Diagnostics Market
8
China Molecular Diagnostics Market
Profiles of Private Clinical Labs and Diagnostic
Services Companies in China     Zhejiang Dian
Diagnostics Technology Co., Ltd    ADICON
Clinical Laboratories    Guangzhou Kingmed
Diagnostics Center Co. Ltd.    Kindstar Global
(Privately held)    BGI-Shenzhen (Privately
held)    OriGene Technologies (Privately held)
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlchina-molecular-diagnostics-market-test-volume
-and-forecast-491-p.php
China Molecular Diagnostics Market
9
China Molecular Diagnostics Market
China Molecular Diagnostics Market
10
Contact Us
China Molecular Diagnostics Market